Corbus Pharmaceuticals Holdings, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 30 →Insiders1 insider bought $101,205 in 2 open-market buys. 10 insiders sold $1.4M, 9 of 14 sales on a 10b5-1 plan.→HoldersCormorant 12.6%Orbimed 9.3%BlackRock 7.1%→Financing →PeersClosest companies: NVCT, RKTO, ARTL→
From the filings
Figures
- Net income
- −$101.9Mlast 12 months
- Operating cash flow
- −$73.6Mlast 12 months
- Cash and equivalents
- $23.4Mat the last balance sheet
- Shares outstanding
- 18.7M shareson issue